IRTC Stock Forecast 2025-2026
Distance to IRTC Price Targets
IRTC Price Momentum
10 Quality Stocks Worth Considering Now
Researching iRhythm (IRTC) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on IRTC and similar high-potential opportunities.
Latest IRTC Stock Price Targets & Analyst Predictions
Based on our analysis of 17 Wall Street analysts, IRTC has a bullish consensus with a median price target of $130.00 (ranging from $104.00 to $152.00). The overall analyst rating is Strong Buy (8.9/10). Currently trading at $100.96, the median forecast implies a 28.8% upside. This outlook is supported by 11 Buy, 2 Hold, and 0 Sell ratings.
The most optimistic forecast comes from William Plovanic at Canaccord Genuity, projecting a 50.6% upside. Conversely, the most conservative target is provided by Nathan Treybeck at Wells Fargo, suggesting a 3.0% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
IRTC Analyst Ratings
IRTC Price Target Range
Latest IRTC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for IRTC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Feb 24, 2025 | Goldman Sachs | David Roman | Neutral | Maintains | $124.00 |
| Feb 21, 2025 | Wells Fargo | Nathan Treybeck | Equal-Weight | Maintains | $104.00 |
| Feb 21, 2025 | Needham | David Saxon | Buy | Maintains | $138.00 |
| Feb 21, 2025 | Truist Securities | Richard Newitter | Buy | Maintains | $145.00 |
| Jan 13, 2025 | Needham | David Saxon | Buy | Maintains | $112.00 |
| Jan 8, 2025 | Oppenheimer | Suraj Kalia | Outperform | Maintains | $120.00 |
| Dec 18, 2024 | Truist Securities | Richard Newitter | Buy | Maintains | $111.00 |
| Dec 9, 2024 | Canaccord Genuity | William Plovanic | Buy | Maintains | $152.00 |
| Dec 3, 2024 | Wells Fargo | Nathan Treybeck | Equal-Weight | Reinstates | $86.00 |
| Nov 1, 2024 | Baird | Mike Polark | Outperform | Maintains | $79.00 |
| Oct 31, 2024 | Needham | David Saxon | Buy | Maintains | $96.00 |
| Oct 22, 2024 | Truist Securities | Richard Newitter | Buy | Maintains | $95.00 |
| Oct 14, 2024 | Truist Securities | Richard Newitter | Buy | Maintains | $80.00 |
| Oct 4, 2024 | Goldman Sachs | David Roman | Neutral | Initiates | $78.00 |
| Sep 25, 2024 | Canaccord Genuity | William Plovanic | Buy | Maintains | $137.00 |
| Aug 22, 2024 | Citigroup | Joanne Wuensch | Buy | Maintains | $110.00 |
| Aug 2, 2024 | JP Morgan | Allen Gong | Overweight | Maintains | $100.00 |
| Aug 2, 2024 | Truist Securities | Richard Newitter | Buy | Reiterates | $117.00 |
| Aug 2, 2024 | Needham | David Saxon | Buy | Maintains | $119.00 |
| Aug 2, 2024 | Baird | Mike Polark | Outperform | Maintains | $110.00 |
Irhythm Technologies Inc. (IRTC) Competitors
The following stocks are similar to iRhythm based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Irhythm Technologies Inc. (IRTC) Financial Data
Irhythm Technologies Inc. has a market capitalization of $3.22B with a P/E ratio of -27.8x. The company generates $591.84M in trailing twelve-month revenue with a -19.1% profit margin.
Revenue growth is +24.0% quarter-over-quarter, while maintaining an operating margin of -0.8% and return on equity of -75.3%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Irhythm Technologies Inc. (IRTC) Business Model
About Irhythm Technologies Inc.
Develops remote monitoring solutions for cardiac arrhythmias.
The company generates revenue through its Zio service, which combines wearable biosensors with cloud-based analytics for continuous heart monitoring. This innovative platform enables healthcare providers to detect and diagnose irregular heart rhythms more efficiently, thus improving patient care and clinical outcomes.
Irhythm Technologies operates at the intersection of healthcare and technology, significantly impacting the medical devices sector. By addressing unmet needs in cardiovascular care, it enhances accessibility and effectiveness in cardiac health management, moving care from clinical settings to personalized home environments.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
2,000
CEO
Mr. Quentin S. Blackford
Country
United States
IPO Year
2016
Website
www.irhythmtech.comIrhythm Technologies Inc. (IRTC) Latest News & Analysis
iRhythm Technologies (NASDAQ: IRTC) will release Q1 2025 financial results on May 1, 2025, after market close, followed by a conference call at 1:30 p.m. on the same day.
iRhythm Technologies' upcoming financial results release could impact stock performance and investor sentiment, revealing insights into growth and operational health.
iRhythm Technologies (NASDAQ: IRTC) released its 2024 Corporate Sustainability Report, detailing its initiatives for sustainability and inclusivity.
iRhythm Technologies' sustainability report may attract socially conscious investors, potentially enhancing its stock appeal and influencing market perception positively.
iRhythm Technologies presented new findings at the ACC 2025, showing that short-term ECG monitoring often misses actionable arrhythmias, highlighting the effectiveness of their Zio® long-term monitoring.
The findings highlight the effectiveness of iRhythm's Zio® ECG devices over traditional methods, potentially increasing demand and market share, which could boost stock performance.
iRhythm Technologies (IRTC) has been upgraded to Zacks Rank #2 (Buy), indicating improved earnings outlook, which may boost the stock price in the near term.
iRhythm Technologies' upgrade to a Zacks Rank #2 signals positive earnings outlook, potentially boosting investor confidence and driving the stock price up.
iRhythm Technologies (NASDAQ: IRTC) will hold its Q4 2024 earnings conference call on February 20, 2025, at 4:30 PM ET, featuring key company executives and analysts from major firms.
The upcoming earnings call for iRhythm Technologies could influence investor sentiment and stock price, providing insights on financial performance and future growth potential.
iRhythm Technologies, Inc. (NASDAQ: IRTC) reported its financial results for Q4 and the full year of 2024 on February 20, 2025, focusing on disease detection and prevention solutions.
iRhythm's financial results indicate company performance, impacting stock valuation and investors' sentiment on future growth in digital health solutions.
Frequently Asked Questions About IRTC Stock
What is Irhythm Technologies Inc.'s (IRTC) stock forecast for 2025?
Based on our analysis of 17 Wall Street analysts, Irhythm Technologies Inc. (IRTC) has a median price target of $130.00. The highest price target is $152.00 and the lowest is $104.00.
Is IRTC stock a good investment in 2025?
According to current analyst ratings, IRTC has 11 Buy ratings, 2 Hold ratings, and 0 Sell ratings. The stock is currently trading at $100.96. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for IRTC stock?
Wall Street analysts predict IRTC stock could reach $130.00 in the next 12 months. This represents a 28.8% increase from the current price of $100.96. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Irhythm Technologies Inc.'s business model?
The company generates revenue through its Zio service, which combines wearable biosensors with cloud-based analytics for continuous heart monitoring. This innovative platform enables healthcare providers to detect and diagnose irregular heart rhythms more efficiently, thus improving patient care and clinical outcomes.
What is the highest forecasted price for IRTC Irhythm Technologies Inc.?
The highest price target for IRTC is $152.00 from William Plovanic at Canaccord Genuity, which represents a 50.6% increase from the current price of $100.96.
What is the lowest forecasted price for IRTC Irhythm Technologies Inc.?
The lowest price target for IRTC is $104.00 from Nathan Treybeck at Wells Fargo, which represents a 3.0% increase from the current price of $100.96.
What is the overall IRTC consensus from analysts for Irhythm Technologies Inc.?
The overall analyst consensus for IRTC is bullish. Out of 17 Wall Street analysts, 11 rate it as Buy, 2 as Hold, and 0 as Sell, with a median price target of $130.00.
How accurate are IRTC stock price projections?
Stock price projections, including those for Irhythm Technologies Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.